Replies to post #227886 on Biotech Values

[DewDiligence]

(ITCI)—BMY has a financial stake in Caplyta, based on a 15-year-old deal (https://ir.intracellulartherapies.com/news-releases/news-release-details/intra-cellular-therapies-inc-receives-exclusive-license-central ).